Literature DB >> 29371086

Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR.

Debra L Monticciolo1, Mary S Newell2, Linda Moy3, Bethany Niell4, Barbara Monsees5, Edward A Sickles6.   

Abstract

Early detection decreases breast cancer mortality. The ACR recommends annual mammographic screening beginning at age 40 for women of average risk. Higher-risk women should start mammographic screening earlier and may benefit from supplemental screening modalities. For women with genetics-based increased risk (and their untested first-degree relatives), with a calculated lifetime risk of 20% or more or a history of chest or mantle radiation therapy at a young age, supplemental screening with contrast-enhanced breast MRI is recommended. Breast MRI is also recommended for women with personal histories of breast cancer and dense tissue, or those diagnosed by age 50. Others with histories of breast cancer and those with atypia at biopsy should consider additional surveillance with MRI, especially if other risk factors are present. Ultrasound can be considered for those who qualify for but cannot undergo MRI. All women, especially black women and those of Ashkenazi Jewish descent, should be evaluated for breast cancer risk no later than age 30, so that those at higher risk can be identified and can benefit from supplemental screening.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Breast cancer screening; breast MRI; breast cancer; breast cancer risk assessment; digital breast tomosynthesis; higher risk populations

Mesh:

Year:  2018        PMID: 29371086     DOI: 10.1016/j.jacr.2017.11.034

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  111 in total

1.  Breast cancer screening.

Authors:  Paula B Gordon
Journal:  Can Fam Physician       Date:  2019-07       Impact factor: 3.275

2.  Breast cancer screening: in the era of personalized medicine, age is just a number.

Authors:  Andrea Cozzi; Simone Schiaffino; Paolo Giorgi Rossi; Francesco Sardanelli
Journal:  Quant Imaging Med Surg       Date:  2020-12

3.  Clinical Benefits, Harms, and Cost-Effectiveness of Breast Cancer Screening for Survivors of Childhood Cancer Treated With Chest Radiation : A Comparative Modeling Study.

Authors:  Jennifer M Yeh; Kathryn P Lowry; Clyde B Schechter; Lisa R Diller; Oguzhan Alagoz; Gregory T Armstrong; John M Hampton; Wendy Leisenring; Qi Liu; Jeanne S Mandelblatt; Diana L Miglioretti; Chaya S Moskowitz; Kevin C Oeffinger; Amy Trentham-Dietz; Natasha K Stout
Journal:  Ann Intern Med       Date:  2020-07-07       Impact factor: 25.391

4.  Comparative Benefit-to-Radiation Risk Ratio of Molecular Breast Imaging, Two-Dimensional Full-Field Digital Mammography with and without Tomosynthesis, and Synthetic Mammography with Tomosynthesis.

Authors:  Matthew Brown; Matthew F Covington
Journal:  Radiol Imaging Cancer       Date:  2019-09-27

5.  Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk.

Authors:  Janie M Lee; Robert F Arao; Brian L Sprague; Karla Kerlikowske; Constance D Lehman; Robert A Smith; Louise M Henderson; Garth H Rauscher; Diana L Miglioretti
Journal:  JAMA Intern Med       Date:  2019-05-01       Impact factor: 21.873

6.  Differences between screen-detected and interval breast cancers among BRCA mutation carriers.

Authors:  Melissa Pilewskie; Emily C Zabor; Elizabeth Gilbert; Michelle Stempel; Oriana Petruolo; Debra Mangino; Mark Robson; Maxine S Jochelson
Journal:  Breast Cancer Res Treat       Date:  2019-01-23       Impact factor: 4.872

7.  Facility Variability in Examination Indication Among Women With Prior Breast Cancer: Implications and the Need for Standardization.

Authors:  Diana S M Buist; Laura Ichikawa; Karen J Wernli; Christoph I Lee; Louise M Henderson; Karla Kerlikowske; Erin J A Bowles; Diana L Miglioretti; Jennifer Specht; Garth H Rauscher; Brian L Sprague; Tracy Onega; Janie M Lee
Journal:  J Am Coll Radiol       Date:  2020-01-28       Impact factor: 5.532

8.  Breast cancer screening in average-risk women: towards personalized screening.

Authors:  Almir Gv Bitencourt; Carolina Rossi Saccarelli; Christiane Kuhl; Elizabeth A Morris
Journal:  Br J Radiol       Date:  2019-09-23       Impact factor: 3.039

9.  MRI-guided core needle biopsy of the breast: Radiology-pathology correlation and impact on clinical management.

Authors:  Amy J Lilly; Meredith Johnson; Cherie M Kuzmiak; David W Ollila; Siobhan M O'Connor; Johann D Hertel; Benjamin C Calhoun
Journal:  Ann Diagn Pathol       Date:  2020-07-03       Impact factor: 2.090

10.  Unveiling the histopathologic spectrum of MRI-guided breast biopsies: an institutional pathological-radiological correlation.

Authors:  Gustavo Moreno; Mariel Molina; Ruizhe Wu; Julie R Sullivan; Julie M Jorns
Journal:  Breast Cancer Res Treat       Date:  2021-05-27       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.